Antiplatelet and Anticoagulation Treatments in Acute Coronary Syndromes

Authors

  • O. Nallet Service de cardiologie GHIRM
  • J. Pascal Service de cardiologie GHIRM
  • D. Millischer Service de cardiologie GHIRM

DOI:

https://doi.org/10.1007/s13546-016-1177-4

Keywords:

Transfusion, Intensive care unit, Red blood cell, Anemia

Abstract

Antithrombotic therapy is an essential part of the management of acute coronary syndromes. Therapy with numerous combinations of antiplatelet and anticoagulant drugs is possible. In general, a more potent antithrombotic effect is associated with a decreased risk of ischemic events but an increased risk of bleeding. Finding the right balance remains a major challenge.

Published

2016-02-01

How to Cite

Nallet, O., Pascal, J., & Millischer, D. (2016). Antiplatelet and Anticoagulation Treatments in Acute Coronary Syndromes. Médecine Intensive Réanimation, 25(2), 155–167. https://doi.org/10.1007/s13546-016-1177-4